SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
8.21
+0.35 (4.45%)
Nov 13, 2026, 4:00 PM EST - Market closed
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $703.25 million as of November 13, 2026. It is the 12,119th most valuable company in the world and the 2,464th biggest in the United States. Its market cap has increased by 139.94% in one year.
Market Cap
703.25M
Enterprise Value
670.64M
1-Year Change
139.94%
Global Rank
Country Rank
#2,464 United States
Category
ChartMarket Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $703.25M, a decrease of -37.23%. That is a compound annual growth rate of -8.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 703.25M | 121.95% |
| Dec 31, 2025 | 316.85M | 55.34% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Certara | 1.76B |
| Omnicell | 1.61B |
| Teladoc Health | 1.60B |
| GoodRx Holdings | 1.21B |
| Omada Health | 889.00M |
| HealthStream | 856.80M |
| Phreesia | 787.68M |
| NRC Health | 563.64M |